Corporate News
Market Performance
Clover Health Investments (ticker CLOV) closed the trading day on Tuesday, 20 October 2026, at USD 4.72 per share, down 0.89 % from the previous close.
- Shares outstanding: 531.2 million
- Market capitalization: USD 2.4 billion
- Volume traded in the last 24 hours: USD 16.9 million
- 24‑hour change since the end of the previous month: down 2.2 %
- 200‑day simple moving average: USD 3.45
- 52‑week high: USD 5.59 (29 June 2026)
- 52‑week low: USD 1.58 (1 April 2026)
Upcoming Events
Clover Health Investments will present its most recent quarterly financial results at a conference scheduled for 4 November 2026. Analysts project that the company will report a modest earnings‑per‑share (EPS) loss for the quarter, an improvement over the prior period. Revenue is expected to rise substantially compared with the same period last year. For the current fiscal year, estimates indicate a positive EPS, reversing last year’s loss, and a notable increase in total sales.
Insider Activity
Several insiders filed Form 4 disclosures on 15 October 2026 reporting routine sales of Class A common shares. These transactions were executed to satisfy tax‑withholding requirements associated with the vesting of restricted stock units and are part of the company’s standard equity incentive plan. The filings also update share ownership percentages for key executives and officers.
Peer Performance (Last 24 Hours)
| Company | Ticker | Price Change | Current Price (USD) | Market Cap (USD) | Notable Recent Event |
|---|---|---|---|---|---|
| Fs Kkr Capital | FSK | –1.84 % | 10.15 | 2.9 billion | – |
| Arcus Biosciences | RCUS | +0.09 % | 24.39 | 2.8 billion | Virtual meeting to present kidney‑cancer drug data |
| Fervo Energy | FRVO | –5.99 % | 9.23 | 2.9 billion | JPMorgan revised price target downward |
| Denali Therapeutics | DNLI | +2.44 % | 19.02 | 2.8 billion | Interim survival data from Phase‑2 DENALI Part 1b presented at ESMO |
| Atricure | ATRC | –0.96 % | 57.74 | 2.9 billion | – |
Company Overview
Clover Health Investments, Corp. is a U.S. health‑care company that offers Medicare Advantage plans. The company provides hospital, medical, and private insurance services nationwide. Further information can be obtained from the company’s website at www.cloverhealth.com . Shares are listed on the Nasdaq exchange.
